Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Clinical trial NCT02924233 · WITHDRAWN
Trial details
- NCT number
- NCT02924233
- Sponsor
- Symphogen A/S
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.